10.1016/S0306-4522(02)00912-0 [DOI] [PubMed] [Google Scholar] Somanath, P
PMID: 33711021 Keywords Alpha Sympathomimetics Brimonidine Trade Names: Alphagan-P, Qoliana, Lumify & generic FDA approved in 1996 Drug Class: Alpha-2 Selective Adrenergic Agonist, Antiglaucoma, Vascular decongestant Mechanism of Action: 2 adrenoreceptor agonist approximately 10-times more selective for alpha-2 receptors compared to clonidine (Cambridge, 1981) does not exhibit significant tachyphylaxis with repeated use (Lee & Kim, 2022) Indications: Prescription & OTC to treat symptoms of: open-angle glaucoma : to lower intraocular pressure or ocular hypertension (Alphagan-P, Qoliana )
Instead, we have an in-depth conversation about your lifestyle, the onset and severity of any symptoms, and any other health concerns that you experience
To date, evidence for its therapeutic effects as an mTOR inhibitor is limited to pharmacological and animal studies, with no established clinical trials (162)
People who are pregnant or nursing During pregnancy, the demand for B vitamins, particularly B12 and folate, grows
The two are not the same thing
